model_id	validation_technique	description	passages_tested	validation_host_strain_nomenclature
TM00037	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00279	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01127	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01007	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01002	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01244	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01245	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00039	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01125	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01120	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01121	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01243	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00274	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01360	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00026	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01237	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01479	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00025	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00388	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01117	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00024	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00387	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01239	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00023	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00386	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01119	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01354	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01234	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01355	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01357	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00381	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01231	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01594	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01353	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00022	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00385	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00263	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00020	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106568	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106569	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106566	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106567	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106564	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106565	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106562	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106563	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01149	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106571	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00058	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01029	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106572	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00057	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00298	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106570	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000094290	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01145	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01267	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01148	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00051	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01141	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00292	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01263	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00170	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01264	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01386	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01144	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00176	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00053	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000117591	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000117590	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000105006	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106573	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106574	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00047	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000099873	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01014	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01135	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01498	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000099999	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01137	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01258	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00282	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01130	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01373	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00165	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00164	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00229	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000102184	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106542	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106543	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106541	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00356	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01325	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01446	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00113	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00355	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00112	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00233	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01448	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01569	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01442	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000096652	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01563	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01443	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01565	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000096896	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000077973	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01441	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00231	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00352	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00351	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000077608	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000104256	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00219	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00339	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00103	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00345	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106560	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000108981	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01557	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106561	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00222	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00107	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00228	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000077960	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00226	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01555	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000116474	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106528	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106529	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106526	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106527	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000099706	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00015	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00136	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00135	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00256	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01348	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00013	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00134	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00376	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00375	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01464	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00139	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01344	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00259	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00016	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00137	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01225	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01346	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01340	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01462	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01220	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01341	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01100	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00253	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000104117	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106535	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106536	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106533	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106534	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106531	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106532	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000105561	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00246	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01215	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01457	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01578	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00244	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00001	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01212	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00368	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01571	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000117541	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000117663	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00360	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000101173	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01517	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00312	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00311	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000118608	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01404	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00314	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01400	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000099207	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000078984	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000099327	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000112064	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000096053	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01509	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000103366	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000108931	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01628	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01629	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00784	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01634	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01513	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01510	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00302	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01632	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000092712	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00208	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00213	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00334	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01303	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01545	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00212	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00332	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00694	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000077636	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000078604	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01427	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00214	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00335	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01302	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01423	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00330	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000080739	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000093933	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000104314	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00317	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00206	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00327	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00204	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00203	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00324	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01533	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000115417	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000099761	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000115416	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00877	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000115419	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000115418	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000077451	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000111056	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000111054	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00857	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00977	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00862	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00860	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00980	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000115420	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000095054	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000102326	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01619	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00889	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000102680	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01617	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01618	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00896	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01500	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000104518	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000101006	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000101005	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000099318	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00999	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000101121	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00884	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01611	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000097253	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01612	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00881	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00888	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00887	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000103634	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000105934	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00945	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00702	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000104720	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000100365	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00832	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00939	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000096904	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000101220	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000112358	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000109079	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00943	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000078336	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00847	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000096913	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00849	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000077591	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000101329	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000101328	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00958	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000096922	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00964	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000078673	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000101892	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000094918	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000114963	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00910	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000102630	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000098169	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000099257	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000119280	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00922	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00929	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00928	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00927	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00926	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000078366	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00931	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00930	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000112882	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000100556	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000100675	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000100674	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00914	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00913	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000100672	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00916	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000094707	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000108157	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000112414	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00921	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00920	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000079689	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000100646	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000096854	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000096976	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01086	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01087	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000103917	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01085	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000101866	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000096869	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000111787	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01079	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000111428	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000096985	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01075	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01076	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000096878	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000109799	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000108112	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000079378	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000096994	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106172	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01092	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000093018	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000111644	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000119129	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01098	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000094100	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01096	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00190	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000096931	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000080230	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106146	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106144	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106145	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00078	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00199	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000104096	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01168	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000111615	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01048	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00073	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00194	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01284	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00072	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00193	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00192	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01044	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01165	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00070	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01045	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00077	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00198	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00076	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01160	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00075	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00196	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000093555	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000096828	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000096949	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01039	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00067	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00188	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01278	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000096940	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00062	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00183	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01031	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01273	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00061	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00060	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01155	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00187	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00065	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00186	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00064	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00185	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00063	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00184	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01030	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00091	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00090	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106124	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000096837	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000096958	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106125	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000107333	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106132	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00099	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00098	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00097	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00096	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01063	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00080	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000095635	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000095633	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000096845	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000096967	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106133	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106134	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000108200	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106142	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106143	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00089	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000106141	Histology, Ki67 IHC, CD45 IHC, STR analysis	The histology of the engrafted tumor retains morphologic features of the primary patient tumor as assessed by a Board Certified Pathologist. IHC for human Ki67 validates that the tumor cells are actively dividing and are of human origin. IHC for CD45 and cytokeratin (AE1/AE3) rules out a xenograft-associated lymphocytic tumor. STR analysis validates provenance of engrafted tumor.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM00084	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01053	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
J000093572	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01171	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
TM01173	Validation is pending.	Validation is pending.	Not Specified	NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ